BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Riggio O, Ridola L, Pasquale C. Hepatic encephalopathy therapy: An overview. World J Gastrointest Pharmacol Ther 2010; 1(2): 54-63 [PMID: 21577297 DOI: 10.4292/wjgpt.v1.i2.54] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Ishida S, Sarada M, Seki H, McGirr L, Lau A, Morishita K. Genotoxicity and subchronic oral toxicity of L-ornithine monohydrochloride. Regul Toxicol Pharmacol 2013;67:360-71. [PMID: 23994624 DOI: 10.1016/j.yrtph.2013.08.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Yanny B, Winters A, Boutros S, Saab S. Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic Approach. Clin Liver Dis 2019;23:607-23. [PMID: 31563214 DOI: 10.1016/j.cld.2019.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Yin X, Zhang F, Xiao J, Wang Y, He Q, Zhu H, Leng X, Zou X, Zhang M, Zhuge Y. Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients. Eur J Gastroenterol Hepatol. 2019;31:1264-1269. [PMID: 31136318 DOI: 10.1097/meg.0000000000001452] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
4 Burkard T, Biedermann A, Herold C, Dietlein M, Rauch M, Diefenbach M. Treatment with a potassium-iron-phosphate-citrate complex improves PSE scores and quality of life in patients with minimal hepatic encephalopathy: a multicenter, randomized, placebo-controlled, double-blind clinical trial. Eur J Gastroenterol Hepatol. 2013;25:352-358. [PMID: 23117470 DOI: 10.1097/MEG.0b013e32835afaa5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
5 Cheng CY, Ho CH, Wang CC, Liang FW, Wang JJ, Chio CC, Chang CH, Kuo JR. One-Year Mortality after Traumatic Brain Injury in Liver Cirrhosis Patients--A Ten-Year Population-Based Study. Medicine (Baltimore). 2015;94:e1468. [PMID: 26448001 DOI: 10.1097/md.0000000000001468] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
6 Zullo A, Hassan C, Ridola L, Lorenzetti R, Campo SM, Riggio O. Rifaximin therapy and hepatic encephalopathy: Pros and cons. World J Gastrointest Pharmacol Ther 2012; 3(4): 62-67 [PMID: 22966484 DOI: 10.4292/wjgpt.v3.i4.62] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
7 Riggio O, Nardelli S, Gioia S, Lucidi C, Merli M. Management of hepatic encephalopathy as an inpatient. Clin Liver Dis (Hoboken) 2015;5:79-82. [PMID: 31040956 DOI: 10.1002/cld.457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Grüngreiff K, Reinhold D, Wedemeyer H. The role of zinc in liver cirrhosis. Annals of Hepatology 2016;15:7-16. [DOI: 10.5604/16652681.1184191] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 12.8] [Reference Citation Analysis]
9 Riggio O, Nardelli S, Moscucci F, Pasquale C, Ridola L, Merli M. Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt. Clinics in Liver Disease 2012;16:133-46. [DOI: 10.1016/j.cld.2011.12.008] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 8.3] [Reference Citation Analysis]
10 Rustgi VK. History of Hepatic Encephalopathy. Clin Liver Dis 2020;24:xiii-vii. [PMID: 32245536 DOI: 10.1016/j.cld.2020.02.001] [Reference Citation Analysis]